domains/health/heart-failure-mortality-rising-since-2012-reversing-decades-of-decline.md

@@ -0,0 +1,27 @@
+---
+type: claim
+domain: health
+description: The 2012 inflection predates COVID by 8 years, indicating structural drivers (metabolic syndrome epidemic, aging population, improved MI survival creating larger chronic HF pool) rather than pandemic effects
+confidence: proven
+source: Heart Failure Society of America (HFSA) 2024/2025 annual statistics, Journal of Cardiac Failure
+created: 2024-05-16
+title: "US heart failure mortality has risen continuously since 2012, reversing decades of decline, and is now 3% higher than 25 years ago despite advances in acute cardiac care"
+agent: vida
+scope: causal
+related_claims: ["[[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]", "[[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated]]"]
+---
+
+# US heart failure mortality has risen continuously since 2012, reversing decades of decline, and is now 3% higher than 25 years ago despite advances in acute cardiac care
+
+HFSA reports document that HF mortality began rising in 2012 after decades of decline, with age-adjusted HF mortality now 3% higher than 25 years ago. The 2020-2021 period showed 'pronounced acceleration' with 425,147 HF-related deaths (45% of all cardiovascular deaths), but the trend began 8 years before COVID. Current prevalence is 6.7 million Americans, projected to reach 11.4 million by 2050. The pre-COVID inflection rules out pandemic as primary cause and points to structural metabolic drivers: the obesity/metabolic syndrome epidemic creates more HF cases, while improved survival from acute MI (due to better acute care) means more patients survive to develop chronic heart failure. This creates a paradox where success in acute cardiac care feeds the chronic HF epidemic.
+
+## Relevant Notes
+- The 2012 inflection point is a key indicator that the rise in HF mortality is due to long-term structural factors rather than acute events like the COVID-19 pandemic.
+- The paradox of improved acute care leading to a larger chronic disease pool highlights the need for a holistic approach to cardiovascular health.
+
+## Topics
+- Heart Failure
+- Mortality Trends
+- Metabolic Syndrome
+- Cardiovascular Disease
+- Public Health

domains/health/heart-failure-now-dominant-cardiovascular-killer-at-45-percent-of-cv-deaths.md

@@ -0,0 +1,9 @@
+{
+  "action": "flag_duplicate",
+  "candidates": [
+    "us-cvd-mortality-bifurcating-ischemic-declining-heart-failure-hypertension-worsening.md",
+    "us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements.md",
+    "hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md"
+  ],
+  "reasoning": "This claim, 'Heart failure now accounts for 45% of cardiovascular deaths, making it the dominant cardiovascular killer and inverting the historical pattern where ischemic heart disease was primary,' is a near-duplicate of existing claims. \n\n- `us-cvd-mortality-bifurcating-ischemic-declining-heart-failure-hypertension-worsening.md` already covers the 'bifurcation' of CVD mortality with ischemic disease declining and HF rising, making HF a significant driver. The 45% figure is new but fits within the scope of this existing claim.\n\n- `us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements.md` details the reversal of HF mortality trends, establishing HF as a growing problem, which underpins its increasing share of CVD deaths.\n\n- `hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause.md` is also relevant as hypertension is a major risk factor for heart failure, contributing to the overall shift in CVD mortality patterns. The proposed claim's assertion of HF as the 'dominant cardiovascular killer' needs to be considered in the context of other rising CVD causes like hypertension."
+}